Study on the absorption of indicator components after ingestion of a new sustained-release formulatio
Not Applicable
- Conditions
- Adult men
- Registration Number
- JPRN-UMIN000050522
- Lead Sponsor
- FANCL Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Subjects with a serious medical history or gastrointestinal surgery. 2) Subjects with diseases affecting gastric excretion and digestion/absorption, or with daily symptoms of indigestion, constipation, diarrhea, etc. 3) Subjects have abnormal renal, hepatic, glucose and lipid metabolic functions. 4) Subjects are taking indicator components-rich drugs or supplements. 5) Subjects are heavy alcohol drinkers or excessive smokers. 6) Subjects who are judged to be unsuitable as subjects by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total urinary excretion of indicator components per 24 hours after ingestion
- Secondary Outcome Measures
Name Time Method rinary indicator components excretion at each time point after ingestion. Tmax of urinary indicator components, Cmax of urinary indicator components.